A

Al-Aqar Healthcare REIT
KLSE:ALAQAR

Watchlist Manager
Al-Aqar Healthcare REIT
KLSE:ALAQAR
Watchlist
Price: 1.39 MYR -0.71%
Market Cap: 1.2B MYR
Have any thoughts about
Al-Aqar Healthcare REIT?
Write Note
Section:
 

Relative Value

The Relative Value of one ALAQAR stock under the Base Case scenario is 1.3 MYR. Compared to the current market price of 1.39 MYR, Al-Aqar Healthcare REIT is Overvalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALAQAR Relative Value
Base Case
1.3 MYR
Overvaluation 6%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

9.7
P/S
P/S
Price to Sales
9.7
vs History
1
vs Industry
21
Median 3Y
8.6
Median 5Y
8.4
Industry
2.2
Forward
9.8
More Details
19.2
P/E
P/E
Price to Earnings
19.2
vs History
20
vs Industry
21
Median 3Y
17.4
Median 5Y
16.3
Industry
17.1
Forward
18
More Details
11
P/OCF
P/OCF
Price to OCF
11
vs History
33
vs Industry
15
Median 3Y
10.3
Median 5Y
10.5
Industry
10.6
More Details
16.8
P/FCFE
P/FCFE
Price to FCFE
16.8
vs History
36
vs Industry
16
Median 3Y
12.9
Median 5Y
15
Industry
14.3
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
1
vs Industry
46
Median 3Y
1
Median 5Y
1
Industry
1.6
More Details
15.3
EV/S
EV/S
Enterprise Value to Sales
15.3
vs History
6
vs Industry
19
Median 3Y
14.5
Median 5Y
14
Industry
3.2
Forward
15.4
More Details
16.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
16.5
vs History
9
vs Industry
23
Median 3Y
15.6
Median 5Y
15.2
Industry
7
More Details
17.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.9
vs History
22
vs Industry
11
Median 3Y
16.9
Median 5Y
16.9
Industry
11.5
Forward
22.1
More Details
17.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
17.9
vs History
22
vs Industry
12
Median 3Y
16.9
Median 5Y
16.9
Industry
13.6
Forward
73.2
More Details
17.5
EV/OCF
EV/OCF
Enterprise Value to OCF
17.5
vs History
53
vs Industry
12
Median 3Y
17.2
Median 5Y
17.9
Industry
11.6
More Details
17.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
17.5
vs History
53
vs Industry
11
Median 3Y
17.2
Median 5Y
17.9
Industry
12.5
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
1
vs Industry
47
Median 3Y
1
Median 5Y
1
Industry
1.5
More Details

Multiples Across Competitors

ALAQAR Competitors Multiples
Al-Aqar Healthcare REIT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Al-Aqar Healthcare REIT
KLSE:ALAQAR
1.2B MYR 9.7 19.2 17.9 17.9
CA
Advance Lithium Corp
XTSX:AALI
559.6B CAD 0 -155 082.8 -862 467.7 -862 467.7
IN
SAB Industries Ltd
BSE:539112
2.8B INR 5.1 -8.7 79.6 84.3
US
GE Vernova LLC
NYSE:GEV
89.2B USD 0 0 0 0
NL
Nepi Rockcastle NV
JSE:NRP
83.7B Zac 0 0 0 0
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
690.7T IDR 21.6 173.9 60 60
US
Coupang Inc
F:788
41B EUR 1.5 42.2 53.8 115.4
IN
Jio Financial Services Ltd
NSE:JIOFIN
2T INR 150.7 122.7 211.4 216.5
CH
Galderma Group AG
SIX:GALD
20.1B CHF 0 0 0 0
US
Reddit Inc
NYSE:RDDT
22.2B USD 19.8 -41.4 -34.4 -33.6
ZA
Fortress Real Estate Investments Ltd
JSE:FFB
19.5B Zac 0 0 0 0
P/E Multiple
Earnings Growth
MY
A
Al-Aqar Healthcare REIT
KLSE:ALAQAR
Average P/E: 89.5
19.2
17%
CA
A
Advance Lithium Corp
XTSX:AALI
Negative Multiple: -155 082.8 N/A
IN
S
SAB Industries Ltd
BSE:539112
Negative Multiple: -8.7 N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-2%
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
173.9
N/A
US
Coupang Inc
F:788
42.2
11%
IN
Jio Financial Services Ltd
NSE:JIOFIN
122.7
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available N/A
US
R
Reddit Inc
NYSE:RDDT
Negative Multiple: -41.4 N/A
ZA
F
Fortress Real Estate Investments Ltd
JSE:FFB
Not Available
-53%

See Also

Summary
ALAQAR intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALAQAR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALAQAR stock valuation using valuation multiples.
Wall Street Estimates
ALAQAR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALAQAR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 197,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.